Skip to main content
Clinical Trials/NCT05915923
NCT05915923
Recruiting
Not Applicable

Effect of Transcranial Magnetic Stimulation on Dynamic Cerebral Autoregulation in Healthy Adults

Yi Yang1 site in 1 country90 target enrollmentAugust 2, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Transcranial Magnetic Stimulation
Sponsor
Yi Yang
Enrollment
90
Locations
1
Primary Endpoint
The differences of phase difference (PD) at 30 minutes after transcranial magnetic stimulation under different stimulation modes (1Hz, 10 Hz, sham stimulation).
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to determine the effect of transcranial magnetic stimulation with different stimulation modes ( 1Hz, 10Hz, sham stimulation ) on cerebral autoregulation.

Detailed Description

Current studies have shown that repetitive transcranial magnetic stimulation (TMS) can change the excitability of nerve cells, improve intracerebral artery blood supply, and even reduce the degree of neurological impairment in patients with ischemic stroke.Dynamic cerebral autoregulation (dCA), refers to a complex process in which small intracranial arteries contract or relax to maintain relatively stable cerebral blood volume when systemic arterial blood pressure changes, which can predict the prognosis of patients with ischemic stroke. In this study, we hypothesis that TMS provides neuro-protection by means of improving dCA.

Registry
clinicaltrials.gov
Start Date
August 2, 2023
End Date
April 20, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Yi Yang
Responsible Party
Sponsor Investigator
Principal Investigator

Yi Yang

Vice President of First Hospital of Jilin University

The First Hospital of Jilin University

Eligibility Criteria

Inclusion Criteria

  • Age≥18 years, \< 60 years, both genders;
  • Willing to participate and sign the informed consent;
  • Bilateral temporal windows were well penetrated;

Exclusion Criteria

  • Complaints of previous or existing chronic organic diseases ( stroke, Parkinson 's disease, hypertension, diabetes, etc. ), mental diseases ( bipolar disorder, personality disorder, schizophrenia, etc. ), or cognitive impairment;
  • Suffering from infectious diseases in late one month;
  • Pregnancy or breast-feeding;
  • Sleep disorders, anxiety and depression,
  • Alcohol or drug abuse;
  • History of prescription drugs or over-the-counter (OTC) drugs in the past 2 weeks;
  • History of epilepsy or family history of epilepsy;
  • Implants ( stents or metals );
  • Other conditions that the researchers think are not suitable for the project.

Outcomes

Primary Outcomes

The differences of phase difference (PD) at 30 minutes after transcranial magnetic stimulation under different stimulation modes (1Hz, 10 Hz, sham stimulation).

Time Frame: 0-30minutes

A cerebral autoregulation parameter derived from transfer function analysis. Continuous cerebral blood flow velocities of bilateral middle cerebral artery will be assessed noninvasively using transcranial Doppler. Spontaneous arterial blood pressure will be simultaneously recorded using a servo-controlled plethysmograph on the left or right middle finger with an appropriate finger cuff size. Transfer function analysis will be used to derive the cerebral autoregulatory parameter.

Secondary Outcomes

  • To compare the difference of phase difference (PD) at 1hour, 6hours and 24hours after transcranial magnetic stimulation under different stimulation modes (1Hz, 10Hz, sham stimulation).(0-1hour; 0-6hours; 0-24hours)

Study Sites (1)

Loading locations...

Similar Trials